Zobrazeno 1 - 10
of 4 710
pro vyhledávání: '"cardiovascular agent"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
OBJECTIVE: We designed a retrospective study to evaluate the performance and outcomes of a novel iopromide-based paclitaxel-coated balloon for the treatment of chronic total occlusion of femoropopliteal arteries. METHODS: Patients with femoropoplitea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10334::e4cdcd729cad70ffd3ac3a4c0347349a
https://hdl.handle.net/20.500.11776/12150
https://hdl.handle.net/20.500.11776/12150
Autor:
Hayley Knight, Heidi E. Steiner, Jason H. Karnes, Kevin Gee, Jason B. Giles, Bonnie L. Hurwitz
Publikováno v:
Pharmacotherapy
Response to cardiovascular drugs can vary greatly between individuals, and the role of the microbiome in this variability is being increasingly appreciated. Recent evidence indicates that bacteria and other microbes are responsible for direct and ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d5af1af114c3722233a11430d8f012
https://doi.org/10.1002/phar.2650
https://doi.org/10.1002/phar.2650
Publikováno v:
Chinese Medical Journal
Chinese Medical Journal, Vol 134, Iss 22, Pp 2656-2665 (2021)
Chinese Medical Journal, Vol 134, Iss 22, Pp 2656-2665 (2021)
Objective:. Cardiovascular diseases are associated with an increased risk of depression, but it remains unclear whether treatment with cardiovascular agents decreases or increases this risk. The effects of drugs on individual usage are also often unk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f314b0999ab6fd87ab57a9171dfed96
https://doi.org/10.1097/cm9.0000000000001875
https://doi.org/10.1097/cm9.0000000000001875
Autor:
Shahrokh Karbalai Saleh, Neda Goodarzi, Marzieh Pazoki, Mahnaz Montazeri, Mehdi Ebrahimi, Seyed Hamidreza Sharifnia, Sina Kazemian, Peimaneh Heydarian, Mohammad Reza Khajavi, Haleh Ashraf, Fatemeh Chichagi, Arya Aminorroaya, Azar Hadadi, Reza Shariat Moharari, Mojgan Mirabdolhagh Hazaveh, Hormat Rahimzadeh, Samira Kafan
Publikováno v:
Journal of Diabetes and Metabolic Disorders
Background The prognostic factors of long-term outcomes in hospitalized patients with diabetes mellitus and COVID-19 are lacking. Methods In this retrospective cohort study, we evaluated patients aged ≥ 18-years-old with the COVID-19 diagnosis who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d25c9d2c98ae6e7b5af458bbb2208cb
http://europepmc.org/articles/PMC8573568
http://europepmc.org/articles/PMC8573568
Autor:
Saad Abdulrahman Hussain, Zainab Saad Abdulrahman, Massara Salah Abbas, Mustafa Mohammed Sabri, Marwa Jamal
Publikováno v:
Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ). 1:72-77
Background: As our society ages, the incidence of chronic diseases increases, and so does drug use and polypharmacy. Aim: To evaluate the medication use behaviors of selected elderly patients who lived in Baghdad city. Methods: This cross-sectional s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29fcd0e7560bfd3e4dc1f57a37a744d3
https://doi.org/10.54133/ajms.v1i.30
https://doi.org/10.54133/ajms.v1i.30
Publikováno v:
Annals of Geriatric Medicine and Research
Annals of Geriatric Medicine and Research, Vol 25, Iss 3, Pp 170-177 (2021)
Annals of Geriatric Medicine and Research, Vol 25, Iss 3, Pp 170-177 (2021)
While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer’s disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::788bfa84624ed3fa178ee04eaea30bbf
https://doi.org/10.4235/agmr.21.0079
https://doi.org/10.4235/agmr.21.0079
Autor:
Katarzyna Krzanowska, Tadeusz Popiela, Andrzej Matyja, Maciej Pilecki, Marek Rajzer, Agnieszka Olszanecka, Artur Gądek, Barbara Katra, Wiktoria Wojciechowska, Aleksander Garlicki, Marek Klocek, Piotr Hydzik, Katarzyna Stolarz-Skrzypek, Mariusz Korkosz, Jerzy Wordliczek, Piotr Chlosta, Monika Bociąga-Jasik, Krzysztof Sładek, Michał Terlecki, Agnieszka Slowik, Tomasz Mach, Paweł Stręk, Marcin Krzanowski, Maciej T. Malecki, Tomasz Grodzicki
Publikováno v:
Kardiologia Polska. 79:773-780
Background: The coronavirus disease 19 (COVID-19) recently became one of the leading causes of death worldwide, similar to cardiovascular disease (CVD). Coexisting CVD may influence the prognosis of patients with COVID-19. Aims: We analyzed the impac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4d9ecf8a7c1847b070634c1fb22ab92
https://doi.org/10.33963/kp.15990
https://doi.org/10.33963/kp.15990
Publikováno v:
International Journal of Research and Review. 8:668-672
Medication related problems (MRPs) can be defined as an event or situation involving drug therapy that potentially interferes with desired health outcome. The aim of the study was to identify the class of drugs that are commonly causing medication re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b499f4c570f6397c09bb38777cee6c60
https://doi.org/10.52403/ijrr.20210888
https://doi.org/10.52403/ijrr.20210888
Autor:
Hiromi Rakugi, Koichi Yamamoto
Publikováno v:
Hypertension Research. 44:1239-1250
Angiotensin receptor-neprilysin inhibitors (ARNIs) are a new class of cardiovascular agents characterized by their dual action on the major regulators of the cardiovascular system, including the renin-angiotensin system (RAS) and the natriuretic pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a33254c1accda7d8439d0f067a65fc5
https://doi.org/10.1038/s41440-021-00706-1
https://doi.org/10.1038/s41440-021-00706-1